Drug General Information
Drug ID
D03FPU
Former ID
DAP001496
Drug Name
Methamfetamine
Drug Type
Small molecular drug
Indication Pain; Inflammatory diseases [ICD9: 338,780; ICD10:R52, G89] Approved [536103]
Therapeutic Class
Analgesics
Structure
Download
2D MOL

3D MOL

Formula
C10H15N
Canonical SMILES
CC(CC1=CC=CC=C1)NC
InChI
1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1
InChIKey
MYWUZJCMWCOHBA-VIFPVBQESA-N
CAS Number
CAS 537-46-2
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:6809
SuperDrug ATC ID
N06BA03
SuperDrug CAS ID
cas=000537462
Target and Pathway
Target(s) D(2) dopamine receptor Target Info Agonist [536103]
KEGG Pathway Rap1 signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Alcoholism
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
Reactome Dopamine receptors
G alpha (i) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic Neurons
References
Ref 536103Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.
Ref 536103Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.